Is ResMed Inc. overvalued?

ResMed Inc. (RMD) looks undervalued — trading about 37% below its fair value.

Undervalued

Price

$200.29

Fair value

$274.02

Current P/E

21.1

Normal P/E

28.8

Market cap

$29.05B

Dividend yield

0.8%

Return on equity

23.5%

Sector

Healthcare

Fair value compares RMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks